130 related articles for article (PubMed ID: 21832875)
1. [Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin].
Kanda S; Inoue T; Tsuruta H; Chiba S; Obara T; Saito M; Kumazawa T; Tsuchiya N; Satoh S; Habuchi T
Hinyokika Kiyo; 2011 Jul; 57(7):385-9. PubMed ID: 21832875
[TBL] [Abstract][Full Text] [Related]
2. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma.
Nanus DM; Garino A; Milowsky MI; Larkin M; Dutcher JP
Cancer; 2004 Oct; 101(7):1545-51. PubMed ID: 15378501
[TBL] [Abstract][Full Text] [Related]
3. [Granulocyte-colony stimulating factor producing squamous cell carcinoma of the renal pelvis: a case report].
Fukuhara H; Tamura K; Yamasaki I; Kamada M; Nishikawa H; Matumoto M; Inoue K; Shuin T
Hinyokika Kiyo; 2010 Sep; 56(9):505-8. PubMed ID: 20940525
[TBL] [Abstract][Full Text] [Related]
4. [Granulocyte-colony stimulating factor-producing urothelial carcinoma of right renal pelvis : a case report].
Nomura Y; Kobayashi M; Enomoto H; Imai H; Wakita T; Yamamoto I; Kise H
Hinyokika Kiyo; 2013 Nov; 59(11):737-41. PubMed ID: 24322413
[TBL] [Abstract][Full Text] [Related]
5. Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature.
Milowsky MI; Rosmarin A; Tickoo SK; Papanicolaou N; Nanus DM
Cancer; 2002 Jan; 94(1):111-6. PubMed ID: 11815966
[TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract.
Dodd PM; McCaffrey JA; Hilton S; Mazumdar M; Herr H; Kelly WK; Icasiano E; Boyle MG; Bajorin DF
J Clin Oncol; 2000 Feb; 18(4):840-6. PubMed ID: 10673526
[TBL] [Abstract][Full Text] [Related]
7. Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma.
Roubaud G; Gross-Goupil M; Wallerand H; de Clermont H; Dilhuydy MS; Ravaud A
Oncology; 2011; 80(3-4):214-8. PubMed ID: 21720184
[TBL] [Abstract][Full Text] [Related]
8. Collecting duct carcinoma producing granulocyte-colony-stimulating factor (G-CSF).
Sugiura S; Makiyama K; Nakaigawa N; Yao M; Kubota Y; Oshiro H
Int J Urol; 2007 Jun; 14(6):555-7. PubMed ID: 17593104
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor.
Kyono Y; Takayama T; Kinoshita M; Kurita Y; Mugiya S; Baba S; Ozono S
Int J Clin Oncol; 2011 Jun; 16(3):275-8. PubMed ID: 20845054
[TBL] [Abstract][Full Text] [Related]
10. [Autopsy of anaplastic carcinoma of the pancreas producing granulocyte colony-stimulating factor].
Hayashi H; Eguchi N; Sumimoto K; Matsumoto K; Azakami T; Sumida T; Tamura T; Sumii M; Uraoka N; Shimamoto F
Nihon Shokakibyo Gakkai Zasshi; 2016 Aug; 113(8):1408-15. PubMed ID: 27498938
[TBL] [Abstract][Full Text] [Related]
11. [Marked efficacy of multimodality therapy for ureteral cancer producing granulocyte colony-stmimulating factor].
Nomura S; Nemoto K; Shioji G; Miura T; Tsuboi N; Abe H; Kondo Y
Nihon Hinyokika Gakkai Zasshi; 2014 Apr; 105(2):43-6. PubMed ID: 24908815
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation.
Staehler M; Haseke N; Roosen A; Stadler T; Bader M; Siebels M; Karl A; Stief CG
Eur J Med Res; 2010; 15(7):287-91. PubMed ID: 20696639
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.
Haas NB; Lin X; Manola J; Pins M; Liu G; McDermott D; Nanus D; Heath E; Wilding G; Dutcher J
Med Oncol; 2012 Jun; 29(2):761-7. PubMed ID: 21298497
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib.
Staehler M; Haseke N; Schöppler G; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG
Eur J Med Res; 2008 Nov; 13(11):531-5. PubMed ID: 19073390
[TBL] [Abstract][Full Text] [Related]
15. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma.
Perez-Zincer F; Olencki T; Budd GT; Peereboom D; Elson P; Bukowski RM
Invest New Drugs; 2002 Aug; 20(3):305-10. PubMed ID: 12211213
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5-fluorouracil and gemcitabine.
Tippin DB; Reeves W; Vogelzang NJ
J Urol; 1999 Jul; 162(1):155-6. PubMed ID: 10379761
[No Abstract] [Full Text] [Related]
18. A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma.
Ryan CW; Vogelzang NJ; Stadler WM
Cancer; 2002 May; 94(10):2602-9. PubMed ID: 12173327
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide, doxorubicin, and gemcitabine combination chemotherapy for treatment of metastatic and locally advanced breast cancer.
Levin M; Durgam S; Novetsky A
Cancer Invest; 2002; 20(7-8):872-5. PubMed ID: 12449716
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience.
Passardi A; Massa I; Zoli W; Gianni L; Milandri C; Zumaglini F; Nanni O; Maltoni R; Frassineti GL; Amadori D
BMC Cancer; 2006 Mar; 6():76. PubMed ID: 16551351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
